Use of AI technology on scale may enable the pharmacovigilance industry to increase operational efficiency and the consistency of data quality when processing individual case safety reports（ICSRs）. MedAI’s AI platform is mainly focusing on the PV signal management of artificial intelligence algorithm and deep mining of PV database. It includes clinical stage and post marketing pharmacovigilance services, and provides risk signal early warning modules.
Increasing Amount of ICSRs Data
Efficient Drug System
DS Professionals’ Skillsets
Establishing a solid pharmacovigilance system is the cornerstone of new drugs research and development. The innovative AI technologies applied in pharmacovigilance provide an opportunity to further increase the efficiency of case handling, while maintaining consistent high quality and compliance standards. By using AI to accelerate the monitoring of patient safety data, MedAI’s experts hope to find any potential drug-related side effects earlier, give early warning in time, and effectively avoid potential safety risks in advance, by continuously train and track the signal.
Deep Neural Network
The innovative ability to apply advanced AI and machine learning technologies to pharmacovigilance provides an opportunity for us to further increase the efficiency of pharmacovigilance operation mode and case handling, while maintaining consistent high quality and compliance standards. Applying advanced AI technology, as well as important process and domain expertise, will open a new era of pharmacovigilance.
Our platform services are mainly about the pharmacovigilance signal management of artificial intelligence algorithm and data mining of pharmacovigilance database. It includes clinical stage pharmacovigilance and post marketing pharmacovigilance services, and provides certification docking services and AI risk signal early warning modules.
Tech Trends in Artificial Intelligence What's up, what's down, what lies ahead, only found in MedAI!